Vimarsana
Biggest News Aggregation in the World

Disorders Laboratory News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Disorders Laboratory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Disorders Laboratory Today - Breaking & Trending Today

AI App Demonstrates Comparable Performance to Standard Mental Health Questionnaires in Assessing Depression - Vimarsana News

AI App Demonstrates Comparable Performance to Standard Mental Health Questionnaires in Assessing Depression

A new mental health assessment powered by artificial intelligence is as good at assessing depression symptoms as the “gold standard” questionnaires currently in broad use in health care, according to researchers at The University of Texas at Austin.

AI App Proves Equal to Standard Mental Health Questionnaires in Assessing Depression - Vimarsana News

AI App Proves Equal to Standard Mental Health Questionnaires in Assessing Depression

AUSTIN, Texas — A new mental health assessment powered by artificial intelligence is as good at assessing depression symptoms as the “gold standard”

Source: utexas.edu
Koneska launches academic collaboration for Parkinson's Disease - Vimarsana News

Koneska launches academic collaboration for Parkinson's Disease

Healthcare technology company Koneska is extending its contribution to critical neuroscience research by collaborating with an academic partnership program.

Koneksa launches academic collaboration for Parkinson's research - Vimarsana News

Koneksa launches academic collaboration for Parkinson's research

Digital biomarker company Koneksa has launched the first collaboration in the Koneska Academic Partnership Program for Parkinson’s Disease (KAPP-PD) to incorporate its Neuroscience Toolkit into research programs.

Koneksa Launches Academic Collaboration Program for Parkinson's Disease | Ap - Vimarsana News

Koneksa Launches Academic Collaboration Program for Parkinson's Disease | Ap

NEW YORK--(BUSINESS WIRE)--Aug 14, 2023--